Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NCAG1 Inhibitors

NCAG1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of NCAG1, a protein that is thought to play a role in cellular growth, metabolism, or signaling pathways. While the exact biological functions of NCAG1 remain under investigation, proteins in this family are typically involved in critical regulatory mechanisms that control cellular processes such as transcription, protein-protein interactions, or metabolic pathways. By inhibiting NCAG1, researchers can explore its specific contributions to these processes, studying how its regulation affects cellular homeostasis, signal transduction, and other aspects of cellular function.

The mechanism of action for NCAG1 inhibitors generally involves binding to key functional domains of the protein, preventing it from interacting with its molecular partners or executing its biological role. Structurally, NCAG1 inhibitors may mimic natural substrates or ligands of the protein, competitively blocking its active site or binding regions essential for its activity. Alternatively, inhibitors may interact with allosteric sites on NCAG1, inducing conformational changes that render the protein inactive. Through the inhibition of NCAG1, researchers gain valuable insights into how this protein influences broader signaling or metabolic pathways and how its activity modulates cellular dynamics. These inhibitors are essential for elucidating the molecular mechanisms behind NCAG1's role in maintaining cellular balance, providing deeper understanding into the regulatory networks that depend on this protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

A polysulfonated naphthylurea that inhibits various growth factors and enzymes, potentially impacting glycosaminoglycan-related pathways.

Fondaparinux

104993-28-4sc-507424
10 mg
$297.00
(0)

A synthetic pentasaccharide that inhibits Factor Xa, potentially influencing dermatan sulfate-associated coagulation pathways.

N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3

808118-40-3 unlabeledsc-488006
10 mg
$12000.00
(0)

A mixture of heparan sulfate, dermatan sulfate, and chondroitin sulfate, affecting anticoagulation pathways.

Chondroitinase ABC from Proteus vulgaris

9024-13-9sc-507341
2 U
$650.00
(0)

An enzyme that degrades chondroitin sulfate and dermatan sulfate, potentially altering their biological functions.

Heparin

9005-49-6sc-507344
25 mg
$119.00
1
(0)

An anticoagulant that interacts with various glycosaminoglycans and may affect pathways related to dermatan sulfate.

Warfarin

81-81-2sc-205888
sc-205888A
1 g
10 g
$73.00
$246.00
7
(1)

An anticoagulant that inhibits vitamin K epoxide reductase, indirectly affecting glycosaminoglycan-related coagulation processes.

Rivaroxaban

366789-02-8sc-208311
2 mg
$158.00
18
(1)

A direct Factor Xa inhibitor, potentially influencing coagulation pathways related to dermatan sulfate.

Apixaban

503612-47-3sc-364406
sc-364406A
10 mg
50 mg
$240.00
$634.00
2
(1)

Another Factor Xa inhibitor, potentially affecting coagulation processes involving dermatan sulfate.

Dabigatran

211914-51-1sc-481166
5 mg
$205.00
1
(0)

A direct thrombin inhibitor, possibly impacting coagulation pathways associated with dermatan sulfate.